Inventor · disambiguated record
Jorge Merijn Mathieu Verkade
Also filed as: VERKADE JORGE · VERKADE JORGE MERIJN MATHIEU
12 granted patents·10 pending applications·39 citations·filing 2007–2025
87Inventor score
Top patents by PatentIndex Score
22 records- 0192US9636421B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2016·Granted May 2, 2017·14 cites·15 claims
- 0291US11338043B2Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted May 24, 2022·8 cites·10 claims
- 0390US10072096B2Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2014·Granted Sep 11, 2018·9 cites·15 claims
- 0488US10792369B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2017·Granted Oct 6, 2020·3 cites·25 claims
- 0586US11547763B2Enediyne conjugatesSYNAFFIX BV·Filed 2020·Granted Jan 10, 2023·3 cites·25 claims
- 0685US11850286B2Sulfamide linker, conjugates thereof, and methods of preparationSYNAFFIX BV·Filed 2020·Granted Dec 26, 2023·1 cites·28 claims
- 0778US11951175B2Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2017·Granted Apr 9, 2024·1 cites·21 claims
- 0874US2024398971A1Bioconjugates containing sulfamide linkers for use in treatmentSYNAFFIX BV·Filed 2024·Application pending·0 cites
- 0972US2025304611A1Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2025·Application pending·0 cites
- 1070US2023127659A1Antibody-conjugates with improved therapeutic index for targeting her2 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 1168US12281135B2Synthesis of 6-azido-6-deoxy-2-n-acetyl-hexosamine-nucleoside diphosphateSYNAFFIX BV·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 1265US2023346965A1Enediyne conjugatesSYNAFFIX BV·Filed 2023·Application pending·0 cites
- 1363US2023338562A1Methods for the preparation of linker payload constructsSYNAFFIX BV·Filed 2022·Application pending·0 cites
- 1462US11957763B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2020·Granted Apr 16, 2024·0 cites·20 claims
- 1560US11590239B2Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugatesSYNAFFIX BV·Filed 2017·Granted Feb 28, 2023·0 cites·9 claims
- 1659US2019225706A1Modified glycoprotein, protein-conjugate and process for the preparation thereofSYNAFFIX BV·Filed 2018·Application pending·0 cites
- 1758US10874746B2Sulfamide linkers for use in bioconjugatesSYNAFFIX BV·Filed 2017·Granted Dec 29, 2020·0 cites·14 claims
- 1858US2022096652A1Acetal-based cleavable linkersSYNAFFIX BV·Filed 2021·Application pending·0 cites
- 1954US12397063B2Antibody-conjugates for targeting of tumours expressing Trop-2SYNAFFIX BV·Filed 2021·Granted Aug 26, 2025·0 cites·21 claims
- 2054US2016235861A1Glycoengineered antibody, antibody-conjugate and methods for their preparationSYNAFFIX BV·Filed 2014·Application pending·0 cites
- 2142US2013066063A1Bicyclo[6.1.0]non-4-yne regents for chemical modification of oligonucleotidesHODGES JOHN COOKE·Filed 2012·Application pending·0 cites
- 2233US2009198084A1Process for the deprotection of protected aminesALSTERS PAULUS LAMBERTUS·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jorge Merijn Mathieu Verkade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →